Excessive false-positive errors in single-arm phase II trials: A simulation-based analysis

被引:0
|
作者
Tang, H. [1 ]
Foster, N. R. [1 ]
Grothey, A. [1 ]
Ansell, S. M. [1 ]
Sargent, D. J. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6512
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Stopping for efficacy in single-arm phase II clinical trials
    Rahman, Rezoanoor
    Iftakhar Alam, M.
    JOURNAL OF APPLIED STATISTICS, 2022, 49 (10) : 2447 - 2466
  • [2] Adaptive designs for single-arm phase II trials in oncology
    Englert, Stefan
    Kieser, Meinhard
    PHARMACEUTICAL STATISTICS, 2012, 11 (03) : 241 - 249
  • [3] Sources of bias for single-arm phase II cancer clinical trials
    Jung, Sin-Ho
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (18)
  • [4] Optimal adaptive single-arm phase II trials under quantified uncertainty
    Kunzmann, Kevin
    Kieser, Meinhard
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (01) : 89 - 103
  • [5] Curtailment in single-arm two-stage phase II oncology trials
    Kunz, Cornelia U.
    Kieser, Meinhard
    BIOMETRICAL JOURNAL, 2012, 54 (04) : 445 - 456
  • [6] A new statistical decision rule for single-arm phase II oncology trials
    Chen, Yiyi
    Chen, Zunqiu
    Mori, Motomi
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2016, 25 (01) : 118 - 132
  • [7] Applications of the prediction of satisfaction design for monitoring single-arm phase II trials
    Djeridi, Zohra
    Ghouar, Ahlem
    Boulares, Hamid
    Bouye, Mohamed
    PLOS ONE, 2024, 19 (09):
  • [8] Bayesian Design of Single-arm Phase II Clinical Trials with Continuous Monitoring
    Johnson, Valen E.
    Cook, John D.
    CLINICAL TRIALS, 2009, 6 (03) : 217 - 226
  • [9] Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials
    Pond, Gregory R.
    Abbasi, Saqib
    CLINICAL TRIALS, 2011, 8 (03) : 260 - 269
  • [10] Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials
    Jung, Sin-Ho
    CONTEMPORARY CLINICAL TRIALS, 2015, 42 : 9 - 17